PRF Technologies Ltd.
- Last sale
- Nov 12, 2026 · -3.68%
- Market cap
- $606.35K
- 830.61K shares
- Filings
- 265
FY 2025
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−26.7% FY25 yoy
- $606.35K
- —
- 35.7×
- 0.1×
- -652.60%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $17,000 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported |
Segments
Segments
LineFY2025ShareChange
Solar By Business Segments$17.00K100%—
Clinical Development By Business Segments$0.00——
Total$17.00K
Pharmaceutical preparations
PRF Technologies Ltd. is the 257th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
NTHINeonc Technologies Holdings, Inc.$40.0K51.8%155,404.4%$139.8MLYELLyell Immunopharma, Inc.$36.0K41.0%762,355.6%$384.5MIBOImpact Biomedical Inc.$32.0K—36,993.8%$41.5MTLPHTalphera, Inc.$28.0K—51,035.7%$53.5MJUNSJupiter Neurosciences, Inc.$21.8K—39,662.8%$1.8MSKVISkinvisible, Inc.$20.0K0.0%5,320.2%$1.1MBDPTBioadaptives, Inc.$18.3K44.3%8,523.4%$240.2K
PRFXPRF Technologies Ltd. (this company)$17.0K—29,541.2%$606.3K
GNLXGenelux Corp$8.0K0.0%401,812.5%$86.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
PRF Technologies Ltd. · CIK 1801834 · Engraved from SEC EDGAR